Barclays PLC Sponsored ADR Aktie News

UK bank earnings season starts again on 24 April when Lloyds Banking updates, notes UBS, adding the domestic operators still look good despite an impressive share price run since the start of 2024. NatWest (total return 31%), Barclays (23%) and LBG (11%) have performed well year-to-date but UBS has upgraded its targets for all three and the more in international-focused HSBC.

BlackRock Inc (NYSE:BLK) has lost an appeal in the UK to reclaim tax on the asset manager's US$13.5 billion (£10.8 billion) takeover of Barclays Global Investors in 2009. Following a years-long dispute, Britain's Court of Appeal denied BlackRock's efforts to reclaim funds from HM Revenue & Customs (HMRC) on Thursday.

LONDON & NEW YORK--(BUSINESS WIRE)--As part of Barclays' continued investment in the Energy Transition sector, Rafael Abati has been appointed Co-Head of Energy Transition in EMEA.

UK retail investors are jumping into US technology megacap stocks, with Magnificent Seven technology giants Nvidia Corporation, Microsoft Corp (NASDAQ:MSFT) and Tesla Inc (NASDAQ:TSLA, ETR:TL0) among the most popular ISA investments at the moment. AJ Bell data shows that tech exposure and income-yielding stocks are top of the pile as ISA customers shoot for tax-free capital gains and dividends.

Barclays economics team on Wednesday said it now sees the U.S. Federal Reserve cutting rates just one time in 2024, by 25 basis points (bps), in light of the upside surprise to the consumer price index (CPI) data released today.

British stocks will pick up momentum and see share prices improve as oil prices tick higher and the overhang from Brexit disperses, Barclays PLC (LSE:BARC) believes. The UK has missed out on the AI-led rally which began late last year, Barclays' boss of European equity strategy Emmanuel Cau noted.

The City watchdog has proposed new payment options for investment research to help boost competition, retreating from the 'unbundling' regime it had formerly championed. Fund managers are to be given greater freedom in how they pay for research, the Financial Conduct Authority said, aiming to publish final rules before the end of June.

One of the biggest drags on the share price of consumer group Haleon might be gone by the end of the year suggests Barclays. According to the broker, and based on Pfizer's latest placing, it's possible it and GSK will have entirely sold down by the end of this year, leaving Haleon 100% free float, said the broker.